Nasdaq · CIK 0001759655
PRVA Privia Health Group, Inc.
Insider trading from SEC Form 4. Last filing 39 d ago. Close $20.85 on Oct 9, 2026, +9% from the 52-week low and -26% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
PRVAOct 9, 2026 · close 20.85
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Privia Health Group, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | Matthew Shawn Morris director sell | $341k 13,647 shares | -17% | +32% from low-6% from high | |
| 19Weak | David Mountcastle EVP & Chief Financial Officer sell | $598k 23,887 shares | -12% | +32% from low-6% from high | |
| 41Moderate | Parth Mehrotra Chief Executive Officer sell | $734k 29,682 shares | -7% | +49% from low-2% from high | |
| 46Moderate | David Mountcastle EVP & Chief Financial Officer sell | $83k 3,322 shares | -2% | +49% from low-2% from high | |
| 42Moderate | Parth Mehrotra Chief Executive Officer sell | $753k 32,465 shares | -7% | +40% from low-9% from high | |
| 48Moderate | Matthew Shawn Morris director sell | $241k 10,309 shares | -15% | +40% from low-9% from high | |
| 46Moderate | David Mountcastle EVP & Chief Financial Officer sell | $80k 3,445 shares | -2% | +40% from low-9% from high | |
| 33Weak | David Mountcastle EVP & Chief Financial Officer sell | $126k 5,630 shares | -3% | +33% from low-13% from high | |
| 25Weak | Edward C Fargis EVP & General Counsel sell | $120k 4,967 shares | -5% | - |
Transactions
The last 30 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Opella Finley Ernest director | AGrant or award Common Stock, $0.01 par value per share | +6,350 | $0.00 | $0 | 6,350 | 39 d ago |
| Dec 12, 2025 | Matthew Shawn Morris director | MOption exercise Common Stock, par value $0.01 per share10b5-1 | +13,647 | $2.00 | $27k | 81,835 | Dec 16, 2025 |
| Dec 12, 2025 | David Mountcastle EVP & Chief Financial Officer | MOption exercise Common Stock, par value $0.01 per share10b5-1 | +23,887 | $2.00 | $48k | 196,796 | Dec 16, 2025 |
| Dec 12, 2025 | Matthew Shawn Morris director | SOpen-market sale Common Stock, par value $0.01 per share10b5-1 | -13,647 | $25.01 | $341k | 68,188 | Dec 16, 2025 |
| Dec 12, 2025 | David Mountcastle EVP & Chief Financial Officer | SOpen-market sale Common Stock, par value $0.01 per share10b5-1 | -23,887 | $25.03 | $598k | 172,909 | Dec 16, 2025 |
| Dec 12, 2025 | David Mountcastle EVP & Chief Financial Officer | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -7,698 | $0.00 | $0 | 17,820 | Dec 16, 2025 |
| Dec 12, 2025 | Matthew Shawn Morris director | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -13,647 | $0.00 | $0 | 3,716,652 | Dec 16, 2025 |
| Dec 12, 2025 | David Mountcastle EVP & Chief Financial Officer | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -4,792 | $0.00 | $0 | 12,452 | Dec 16, 2025 |
| Dec 12, 2025 | David Mountcastle EVP & Chief Financial Officer | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -3,430 | $0.00 | $0 | 5,501 | Dec 16, 2025 |
| Dec 12, 2025 | David Mountcastle EVP & Chief Financial Officer | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -7,967 | $0.00 | $0 | 2,866 | Dec 16, 2025 |
| Jul 15, 2025 | Lance Berberian director | AGrant or award Common Stock, $0.01 par value per share | +7,668 | $0.00 | $0 | 7,668 | Jul 17, 2025 |
| May 21, 2025 | Thomas A McCarthy director | AGrant or award Common Stock, $0.01 par value per share | +8,396 | $0.00 | $0 | 19,520 | May 23, 2025 |
| May 21, 2025 | David S Wichmann director | AGrant or award Common Stock, par value $0.01 per share | +8,396 | $0.00 | $0 | 25,709 | May 23, 2025 |
| May 21, 2025 | Jaewon Ryu director | AGrant or award Common Stock, $0.01 par value per share | +8,396 | $0.00 | $0 | 38,647 | May 23, 2025 |
| May 21, 2025 | Matthew Shawn Morris director | AGrant or award Common Stock, par value $0.01 per share | +8,396 | $0.00 | $0 | 68,188 | May 23, 2025 |
| May 21, 2025 | Patricia Anne Maryland director | AGrant or award Common Stock, $0.01 par value per share | +8,396 | $0.00 | $0 | 42,312 | May 23, 2025 |
| May 21, 2025 | Pamela O Kimmet director | AGrant or award Common Stock, par value $0.01 per share | +8,396 | $0.00 | $0 | 25,709 | May 23, 2025 |
| May 21, 2025 | David P King director | AGrant or award Common Stock, $0.01 par value per share | +8,396 | $0.00 | $0 | 42,312 | May 23, 2025 |
| May 21, 2025 | Nancy G Cocozza director | AGrant or award Common Stock, $0.01 par value per share | +8,396 | $0.00 | $0 | 34,351 | May 23, 2025 |
| May 12, 2025 | Parth Mehrotra Chief Executive Officer | SOpen-market sale Common Stock, $0.01 par value per share10b5-1 | -13,773 | $24.99 | $344k | 423,143 | May 14, 2025 |
| May 12, 2025 | David Mountcastle EVP & Chief Financial Officer | SOpen-market sale Common Stock, par value $0.01 per share | -3,322 | $24.99 | $83k | 172,909 | May 14, 2025 |
| May 13, 2025 | Parth Mehrotra Chief Executive Officer | SOpen-market sale Common Stock, $0.01 par value per share10b5-1 | -15,909 | $24.52 | $390k | 407,234 | May 14, 2025 |
| Apr 30, 2025 | Parth Mehrotra Chief Executive Officer | SOpen-market sale Common Stock, $0.01 par value per share10b5-1 | -15,100 | $23.33 | $352k | 454,281 | May 2, 2025 |
| Apr 30, 2025 | Matthew Shawn Morris director | SOpen-market sale Common Stock, par value $0.01 per share | -10,309 | $23.33 | $241k | 59,792 | May 2, 2025 |
| Apr 30, 2025 | David Mountcastle EVP & Chief Financial Officer | SOpen-market sale Common Stock, par value $0.01 per share | -3,445 | $23.33 | $80k | 176,231 | May 2, 2025 |
| May 1, 2025 | Parth Mehrotra Chief Executive Officer | SOpen-market sale Common Stock, $0.01 par value per share10b5-1 | -17,365 | $23.08 | $401k | 436,916 | May 2, 2025 |
| Apr 2, 2025 | David Mountcastle EVP & Chief Financial Officer | SOpen-market sale Common Stock, par value $0.01 per share | -5,630 | $22.38 | $126k | 179,676 | Apr 3, 2025 |
| Mar 10, 2025 | Edward C Fargis EVP & General Counsel | SOpen-market sale Common Stock, $0.01 par value per share | -2,529 | $24.53 | $62k | 95,492 | Mar 12, 2025 |
| Mar 11, 2025 | Edward C Fargis EVP & General Counsel | SOpen-market sale Common Stock, $0.01 par value per share | -2,438 | $23.88 | $58k | 93,054 | Mar 12, 2025 |
| Mar 5, 2025 | Edward C Fargis EVP & General Counsel | AGrant or award Common Stock, $0.01 par value per share | +25,073 | $0.00 | $0 | 98,021 | Mar 7, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Lance Berberianofficer, director
- Nancy G Cocozzadirector
- Opella Finley Ernestdirector
- Edward C FargisEVP & General Counsel
- David P Kingdirector
- Pamela O Kimmetdirector
- Patricia Anne Marylanddirector
- Thomas A McCarthydirector
- Parth MehrotraChief Executive Officer
- Matthew Shawn Morrisdirector
- David MountcastleEVP & Chief Financial Officer
- Jaewon Ryudirector
- David S Wichmanndirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.